Berkle Sheldon 4
4 · Altus Pharmaceuticals Inc. · Filed Mar 6, 2007
Insider Transaction Report
Form 4
Berkle Sheldon
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to buy)
2007-03-04+126,250→ 126,250 totalExercise: $14.24Exp: 2017-03-04→ Common Stock (126,250 underlying)
Footnotes (1)
- [F1]All of such options have a term of ten years vesting over four years, with 1/16th of the options vesting every three months. All of such options become exercisable as they vest. Vesting of these options commenced as of January 1, 2007.